The role of PET scan in monitoring the progression of fibrosing mediastinitis

Abstract We present the case of a 31-year-old man who presented with acute chest pain. Computed tomography scan showed a mediastinal mass engulfing right main-stem bronchus and another mass surrounding descending aorta. Positron emission tomography (PET) scan showed high mass metabolic activity. His...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical imaging 2016-01, Vol.40 (1), p.177-179
Hauptverfasser: Kaya, Hatice, Rider, Katherine, Cho, Alexander H, Schwartz, Arnold, Alrehaili, Ghadah, Ahari, Jalil
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 179
container_issue 1
container_start_page 177
container_title Clinical imaging
container_volume 40
creator Kaya, Hatice
Rider, Katherine
Cho, Alexander H
Schwartz, Arnold
Alrehaili, Ghadah
Ahari, Jalil
description Abstract We present the case of a 31-year-old man who presented with acute chest pain. Computed tomography scan showed a mediastinal mass engulfing right main-stem bronchus and another mass surrounding descending aorta. Positron emission tomography (PET) scan showed high mass metabolic activity. Histopathological evaluation revealed fibroinflammatory scarring. He was diagnosed with idiopathic fibrosing mediastinitis, started on prednisone and tamoxifen treatment, and monitored with serial PET scans. Nine months after treatment initiation, paraaortic abnormality had resolved and mediastinal mass had regressed.
doi_str_mv 10.1016/j.clinimag.2015.07.030
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1778008891</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0899707115002107</els_id><sourcerecordid>1751485166</sourcerecordid><originalsourceid>FETCH-LOGICAL-c517t-41e941f10ff16fd89359390df9a7c41d587fe032d2c0bea830f4e95c350e86593</originalsourceid><addsrcrecordid>eNqNkk1v1DAQhi0EokvhL1SRuHBJmInt2L4gUFU-pCKQWM5W1hkvXrJxsbNI_fc43RakXujJBz_zemYeM3aG0CBg93rXuDFMYd9vmxZQNqAa4PCIrVArXgthzGO2Am1MrUDhCXuW8w5KoRHqKTtpO4FCcrNin9c_qEpxpCr66uvFusqun6owVfs4hTmmMG2ruSBXKW4T5RzitJA-bFLMy-WehtDnufQyh_ycPfH9mOnF7XnKvr-_WJ9_rC-_fPh0_u6ydhLVXAskI9AjeI-dH7Th0nADgze9cgIHqZUn4O3QOthQrzl4QUY6LoF0V9hT9uqYW9r6daA8233IjsaxnygeskWlNIDWBh-ASi6kUqp9CIpCS-y6gr68h-7iIU1l5pvAtjQpVaG6I-XKsnIib69SUZauLYJdNNqdvdNoF40WlC0aS-HZbfxhUxb8t-zOWwHeHgEqW_4dKNnsAk2uyEjkZjvE8P833tyLuMFcP_6ka8r_5rG5tWC_LZ9p-UsoAVoExf8AghrEBg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1753265957</pqid></control><display><type>article</type><title>The role of PET scan in monitoring the progression of fibrosing mediastinitis</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Kaya, Hatice ; Rider, Katherine ; Cho, Alexander H ; Schwartz, Arnold ; Alrehaili, Ghadah ; Ahari, Jalil</creator><creatorcontrib>Kaya, Hatice ; Rider, Katherine ; Cho, Alexander H ; Schwartz, Arnold ; Alrehaili, Ghadah ; Ahari, Jalil</creatorcontrib><description>Abstract We present the case of a 31-year-old man who presented with acute chest pain. Computed tomography scan showed a mediastinal mass engulfing right main-stem bronchus and another mass surrounding descending aorta. Positron emission tomography (PET) scan showed high mass metabolic activity. Histopathological evaluation revealed fibroinflammatory scarring. He was diagnosed with idiopathic fibrosing mediastinitis, started on prednisone and tamoxifen treatment, and monitored with serial PET scans. Nine months after treatment initiation, paraaortic abnormality had resolved and mediastinal mass had regressed.</description><identifier>ISSN: 0899-7071</identifier><identifier>EISSN: 1873-4499</identifier><identifier>DOI: 10.1016/j.clinimag.2015.07.030</identifier><identifier>PMID: 26414539</identifier><identifier>CODEN: CLIMEB</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Abnormalities ; Adult ; Anti-Inflammatory Agents - therapeutic use ; Antigens ; Biopsy ; Coronary vessels ; Diagnosis, Differential ; Disease ; Disease Progression ; Drug dosages ; Family medical history ; Fibrosis ; Humans ; Infections ; Laboratories ; Male ; Mediastinitis ; Mediastinitis - diagnostic imaging ; Mediastinitis - drug therapy ; Mediastinum - diagnostic imaging ; Medical imaging ; Metabolism ; Monitoring ; Pain ; Patients ; PET scan ; Positron emission ; Positron-Emission Tomography ; Prednisone - therapeutic use ; Progressions ; Radiology ; Scars ; Sclerosis - diagnostic imaging ; Sclerosis - drug therapy ; Selective Estrogen Receptor Modulators - therapeutic use ; Serials ; Steroids ; Tamoxifen ; Tamoxifen - therapeutic use ; Tomography</subject><ispartof>Clinical imaging, 2016-01, Vol.40 (1), p.177-179</ispartof><rights>Elsevier Inc.</rights><rights>2015 Elsevier Inc.</rights><rights>Copyright © 2015 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c517t-41e941f10ff16fd89359390df9a7c41d587fe032d2c0bea830f4e95c350e86593</citedby><cites>FETCH-LOGICAL-c517t-41e941f10ff16fd89359390df9a7c41d587fe032d2c0bea830f4e95c350e86593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.clinimag.2015.07.030$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26414539$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kaya, Hatice</creatorcontrib><creatorcontrib>Rider, Katherine</creatorcontrib><creatorcontrib>Cho, Alexander H</creatorcontrib><creatorcontrib>Schwartz, Arnold</creatorcontrib><creatorcontrib>Alrehaili, Ghadah</creatorcontrib><creatorcontrib>Ahari, Jalil</creatorcontrib><title>The role of PET scan in monitoring the progression of fibrosing mediastinitis</title><title>Clinical imaging</title><addtitle>Clin Imaging</addtitle><description>Abstract We present the case of a 31-year-old man who presented with acute chest pain. Computed tomography scan showed a mediastinal mass engulfing right main-stem bronchus and another mass surrounding descending aorta. Positron emission tomography (PET) scan showed high mass metabolic activity. Histopathological evaluation revealed fibroinflammatory scarring. He was diagnosed with idiopathic fibrosing mediastinitis, started on prednisone and tamoxifen treatment, and monitored with serial PET scans. Nine months after treatment initiation, paraaortic abnormality had resolved and mediastinal mass had regressed.</description><subject>Abnormalities</subject><subject>Adult</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Antigens</subject><subject>Biopsy</subject><subject>Coronary vessels</subject><subject>Diagnosis, Differential</subject><subject>Disease</subject><subject>Disease Progression</subject><subject>Drug dosages</subject><subject>Family medical history</subject><subject>Fibrosis</subject><subject>Humans</subject><subject>Infections</subject><subject>Laboratories</subject><subject>Male</subject><subject>Mediastinitis</subject><subject>Mediastinitis - diagnostic imaging</subject><subject>Mediastinitis - drug therapy</subject><subject>Mediastinum - diagnostic imaging</subject><subject>Medical imaging</subject><subject>Metabolism</subject><subject>Monitoring</subject><subject>Pain</subject><subject>Patients</subject><subject>PET scan</subject><subject>Positron emission</subject><subject>Positron-Emission Tomography</subject><subject>Prednisone - therapeutic use</subject><subject>Progressions</subject><subject>Radiology</subject><subject>Scars</subject><subject>Sclerosis - diagnostic imaging</subject><subject>Sclerosis - drug therapy</subject><subject>Selective Estrogen Receptor Modulators - therapeutic use</subject><subject>Serials</subject><subject>Steroids</subject><subject>Tamoxifen</subject><subject>Tamoxifen - therapeutic use</subject><subject>Tomography</subject><issn>0899-7071</issn><issn>1873-4499</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkk1v1DAQhi0EokvhL1SRuHBJmInt2L4gUFU-pCKQWM5W1hkvXrJxsbNI_fc43RakXujJBz_zemYeM3aG0CBg93rXuDFMYd9vmxZQNqAa4PCIrVArXgthzGO2Am1MrUDhCXuW8w5KoRHqKTtpO4FCcrNin9c_qEpxpCr66uvFusqun6owVfs4hTmmMG2ruSBXKW4T5RzitJA-bFLMy-WehtDnufQyh_ycPfH9mOnF7XnKvr-_WJ9_rC-_fPh0_u6ydhLVXAskI9AjeI-dH7Th0nADgze9cgIHqZUn4O3QOthQrzl4QUY6LoF0V9hT9uqYW9r6daA8233IjsaxnygeskWlNIDWBh-ASi6kUqp9CIpCS-y6gr68h-7iIU1l5pvAtjQpVaG6I-XKsnIib69SUZauLYJdNNqdvdNoF40WlC0aS-HZbfxhUxb8t-zOWwHeHgEqW_4dKNnsAk2uyEjkZjvE8P833tyLuMFcP_6ka8r_5rG5tWC_LZ9p-UsoAVoExf8AghrEBg</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Kaya, Hatice</creator><creator>Rider, Katherine</creator><creator>Cho, Alexander H</creator><creator>Schwartz, Arnold</creator><creator>Alrehaili, Ghadah</creator><creator>Ahari, Jalil</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>M7Z</scope><scope>P64</scope><scope>7X8</scope><scope>7QO</scope><scope>7U5</scope><scope>L7M</scope></search><sort><creationdate>20160101</creationdate><title>The role of PET scan in monitoring the progression of fibrosing mediastinitis</title><author>Kaya, Hatice ; Rider, Katherine ; Cho, Alexander H ; Schwartz, Arnold ; Alrehaili, Ghadah ; Ahari, Jalil</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c517t-41e941f10ff16fd89359390df9a7c41d587fe032d2c0bea830f4e95c350e86593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Abnormalities</topic><topic>Adult</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Antigens</topic><topic>Biopsy</topic><topic>Coronary vessels</topic><topic>Diagnosis, Differential</topic><topic>Disease</topic><topic>Disease Progression</topic><topic>Drug dosages</topic><topic>Family medical history</topic><topic>Fibrosis</topic><topic>Humans</topic><topic>Infections</topic><topic>Laboratories</topic><topic>Male</topic><topic>Mediastinitis</topic><topic>Mediastinitis - diagnostic imaging</topic><topic>Mediastinitis - drug therapy</topic><topic>Mediastinum - diagnostic imaging</topic><topic>Medical imaging</topic><topic>Metabolism</topic><topic>Monitoring</topic><topic>Pain</topic><topic>Patients</topic><topic>PET scan</topic><topic>Positron emission</topic><topic>Positron-Emission Tomography</topic><topic>Prednisone - therapeutic use</topic><topic>Progressions</topic><topic>Radiology</topic><topic>Scars</topic><topic>Sclerosis - diagnostic imaging</topic><topic>Sclerosis - drug therapy</topic><topic>Selective Estrogen Receptor Modulators - therapeutic use</topic><topic>Serials</topic><topic>Steroids</topic><topic>Tamoxifen</topic><topic>Tamoxifen - therapeutic use</topic><topic>Tomography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kaya, Hatice</creatorcontrib><creatorcontrib>Rider, Katherine</creatorcontrib><creatorcontrib>Cho, Alexander H</creatorcontrib><creatorcontrib>Schwartz, Arnold</creatorcontrib><creatorcontrib>Alrehaili, Ghadah</creatorcontrib><creatorcontrib>Ahari, Jalil</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><jtitle>Clinical imaging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kaya, Hatice</au><au>Rider, Katherine</au><au>Cho, Alexander H</au><au>Schwartz, Arnold</au><au>Alrehaili, Ghadah</au><au>Ahari, Jalil</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of PET scan in monitoring the progression of fibrosing mediastinitis</atitle><jtitle>Clinical imaging</jtitle><addtitle>Clin Imaging</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>40</volume><issue>1</issue><spage>177</spage><epage>179</epage><pages>177-179</pages><issn>0899-7071</issn><eissn>1873-4499</eissn><coden>CLIMEB</coden><abstract>Abstract We present the case of a 31-year-old man who presented with acute chest pain. Computed tomography scan showed a mediastinal mass engulfing right main-stem bronchus and another mass surrounding descending aorta. Positron emission tomography (PET) scan showed high mass metabolic activity. Histopathological evaluation revealed fibroinflammatory scarring. He was diagnosed with idiopathic fibrosing mediastinitis, started on prednisone and tamoxifen treatment, and monitored with serial PET scans. Nine months after treatment initiation, paraaortic abnormality had resolved and mediastinal mass had regressed.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26414539</pmid><doi>10.1016/j.clinimag.2015.07.030</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0899-7071
ispartof Clinical imaging, 2016-01, Vol.40 (1), p.177-179
issn 0899-7071
1873-4499
language eng
recordid cdi_proquest_miscellaneous_1778008891
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Abnormalities
Adult
Anti-Inflammatory Agents - therapeutic use
Antigens
Biopsy
Coronary vessels
Diagnosis, Differential
Disease
Disease Progression
Drug dosages
Family medical history
Fibrosis
Humans
Infections
Laboratories
Male
Mediastinitis
Mediastinitis - diagnostic imaging
Mediastinitis - drug therapy
Mediastinum - diagnostic imaging
Medical imaging
Metabolism
Monitoring
Pain
Patients
PET scan
Positron emission
Positron-Emission Tomography
Prednisone - therapeutic use
Progressions
Radiology
Scars
Sclerosis - diagnostic imaging
Sclerosis - drug therapy
Selective Estrogen Receptor Modulators - therapeutic use
Serials
Steroids
Tamoxifen
Tamoxifen - therapeutic use
Tomography
title The role of PET scan in monitoring the progression of fibrosing mediastinitis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T08%3A51%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20PET%20scan%20in%20monitoring%20the%20progression%20of%20fibrosing%20mediastinitis&rft.jtitle=Clinical%20imaging&rft.au=Kaya,%20Hatice&rft.date=2016-01-01&rft.volume=40&rft.issue=1&rft.spage=177&rft.epage=179&rft.pages=177-179&rft.issn=0899-7071&rft.eissn=1873-4499&rft.coden=CLIMEB&rft_id=info:doi/10.1016/j.clinimag.2015.07.030&rft_dat=%3Cproquest_cross%3E1751485166%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1753265957&rft_id=info:pmid/26414539&rft_els_id=1_s2_0_S0899707115002107&rfr_iscdi=true